A Novel Genomic Signature with Translational Significance for Human Idiopathic Pulmonary Fibrosis

  • Yasmina Bauer
    Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
  • John Tedrow
    Dorothy P. and Richard P. Simmons Center for Interstitial Lung Diseases, University of Pittsburgh Medical Center–Montefiore, Pittsburgh, Pennsylvania;
  • Simon de Bernard
    AltraBio, Lyon, France; and
  • Magdalena Birker-Robaczewska
    Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
  • Kevin F. Gibson
    Dorothy P. and Richard P. Simmons Center for Interstitial Lung Diseases, University of Pittsburgh Medical Center–Montefiore, Pittsburgh, Pennsylvania;
  • Brenda Juan Guardela
    Dorothy P. and Richard P. Simmons Center for Interstitial Lung Diseases, University of Pittsburgh Medical Center–Montefiore, Pittsburgh, Pennsylvania;
  • Patrick Hess
    Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
  • Axel Klenk
    Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
  • Kathleen O. Lindell
    Dorothy P. and Richard P. Simmons Center for Interstitial Lung Diseases, University of Pittsburgh Medical Center–Montefiore, Pittsburgh, Pennsylvania;
  • Sylvie Poirey
    Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
  • Bérengère Renault
    Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
  • Markus Rey
    Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
  • Edgar Weber
    Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
  • Oliver Nayler
    Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
  • Naftali Kaminski
    Dorothy P. and Richard P. Simmons Center for Interstitial Lung Diseases, University of Pittsburgh Medical Center–Montefiore, Pittsburgh, Pennsylvania;

Journal

Citations (8)*help

See more

Details 詳細情報について

Report a problem

Back to top